|
|
|
Volumn 64, Issue 10, 2001, Pages 1761-1764
|
|
CDC issues guidelines on illnesses associated with intentional release of biologic agents
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN;
CIPROFLOXACIN;
DOXYCYCLINE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TETRACYCLINE DERIVATIVE;
ANTHRAX;
ANTIBIOTIC PROPHYLAXIS;
BIOLOGICAL WARFARE;
BOTULISM;
COMMUNICABLE DISEASE;
GASTROINTESTINAL INFECTION;
HEALTH CARE PERSONNEL;
HEMORRHAGIC FEVER;
HUMAN;
LABORATORY PERSONNEL;
MEDICAL SPECIALIST;
NATIONAL HEALTH SERVICE;
PLAGUE;
PRACTICE GUIDELINE;
PUBLIC HEALTH SERVICE;
RESPIRATORY TRACT INFECTION;
SECONDARY PREVENTION;
SHORT SURVEY;
SMALLPOX;
TULAREMIA;
ANTHRAX;
BIOLOGICAL WARFARE;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
CHEMICAL WARFARE;
DISASTER PLANNING;
HUMANS;
UNITED STATES;
|
|
EID: 0035890812
PISSN: 0002838X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|